Clinical Trial: A multicenter, prospective, exploratory study evaluating an all-oral combination of Ivosidenib, Sonrotoclax, and Chidamide for the treatment of newly diagnosed IDH1-mutated acute myeloid leukemia (China)

China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A multicenter, prospective, exploratory study evaluating an all-oral combination of Ivosidenib, Sonrotoclax, and Chidamide for the treatment of newly diagnosed IDH1-mutated acute myeloid leukemia'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131633

Registration Time: 2026/09/04

Type: Interventional study

Primary Sponsor: The FIrst Affiliated Hospital, College of Medicine, Zhejiang University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337601

Published by HT Digital Content Services with permission from Health Daily Digest....